Let’s face it, investing in drug developers isn’t easy. First, there’s the science risk – the chance that the company’s best drug prospect will fail somewhere during the arduous clinical trial and regulatory approval process. If that weren’t enough,… More
Covance is notorious for its cruel treatment of its laboratory animals and is the subject of a major campaign by Peta. Unlike most industries that use animals, Covance has been totally resistant to negotiation on this issue. I believe this is a sign… More